CIK 0001639691 · Large accelerated filer
LivaNova PLC
Sign in to watch- Ticker
- LIVN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- EIN
- 981268150
- Phone
- 4402033250660
- Business address
- 5220 VALIANT COURT, GLOUCESTER BUSINESS PARK, GLOUCESTER, United Kingdom
- Former names
- Sand Holdco Plc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $819,115
- in 4 filings, $227K under 10b5-1 plans
Net −$819,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-15 | Tezel Ahmet Chief Innovation Officer | Shares withheld for taxes | −1,032 | $45.76 | $47K | 1,935 |
| 2025-06-15 | Tezel Ahmet Chief Innovation Officer | Option exercise · Restricted Stock Units | −2,967 | 8,896 | ||
| 2025-06-15 | PODLOGAR SUSAN M Director | Grant or award · Restricted Stock Units | +4,042 | 4,042 | ||
| 2025-03-30 | Tezel Ahmet Chief Innovation Officer | Grant or award · Restricted Stock Units | +10,222 | 10,222 | ||
| 2025-03-30 | Tezel Ahmet Chief Innovation Officer | Grant or award · Performance Stock Units | +5,111 | 5,111 | ||
| 2025-03-30 | Tezel Ahmet Chief Innovation Officer | Grant or award · Performance Stock Units | +5,111 | 5,111 | ||
| 2025-03-30 | Tezel Ahmet Chief Innovation Officer | Grant or award · Performance Stock Units | +10,222 | 10,222 | ||
| 2025-03-30 | Tezel Ahmet Chief Innovation Officer | Grant or award · Stock Appreciation Rights | +22,378 | 22,378 | ||
| 2025-03-30 | Bolton Stephanie President, Global Epilepsy | Option exercise | +6,024 | 15,586 | ||
| 2025-03-30 | Bolton Stephanie President, Global Epilepsy | Shares withheld for taxes | −2,835 | $39.13 | $111K | 12,751 |
| 2025-03-30 | Bolton Stephanie President, Global Epilepsy | Option exercise · Restricted Stock Units | −426 | 0 | ||
| 2025-03-30 | Bolton Stephanie President, Global Epilepsy | Option exercise · Restricted Stock Units | −457 | 457 | ||
| 2025-03-30 | Bolton Stephanie President, Global Epilepsy | Option exercise · Restricted Stock Units | −1,330 | 2,659 | ||
| 2025-03-30 | Bolton Stephanie President, Global Epilepsy | Option exercise · Restricted Stock Units | −1,229 | 3,686 | ||
| 2025-03-30 | Bolton Stephanie President, Global Epilepsy | Option exercise · Performance Stock Units | −805 | 0 | ||
| 2025-03-30 | Bolton Stephanie President, Global Epilepsy | Option exercise · Performance Stock Units | −717 | 0 | ||
| 2025-03-30 | Bolton Stephanie President, Global Epilepsy | Option exercise · Performance Stock Units | −1,060 | 0 | ||
| 2025-03-30 | Bolton Stephanie President, Global Epilepsy | Grant or award · Restricted Stock Units | +7,027 | 7,027 | ||
| 2025-03-30 | Bolton Stephanie President, Global Epilepsy | Grant or award · Performance Stock Units | +3,513 | 3,513 | ||
| 2025-03-30 | Bolton Stephanie President, Global Epilepsy | Grant or award · Performance Stock Units | +3,513 | 3,513 |
Page 9 of 25 · 489 trades